Literature DB >> 17299408

Efficient transduction of simian cells by HIV-1-based lentiviral vectors that contain mutations in the capsid protein.

Maarten A N Rits1, Karel A van Dort, Carsten Münk, Alexander B Meijer, Neeltje A Kootstra.   

Abstract

Recently, the cyclophilin A (CyPA)-binding region of the HIV-1 capsid protein was identified as a viral determinant involved in the post-entry restriction in Old World monkey cells. Here, we constructed a panel of HIV-1-based lentiviral vectors (LVs) that contain either mutations in the CyPA-binding region or the CyPA-binding region of the related viruses HIV-1 group O and HIV-2. We demonstrated that amino-acid changes in the CyPA-binding region of the capsid can alter the phenotype of the virus resulting in CyPA-independent infection in human cells and non-restricted infection in simian cells. Combining these data with the available structural data, we speculate that reduced affinity of the capsid for CyPA is associated with an unrestricted infection of simian cells. In addition, we observed that primary rhesus macaque peripheral blood mononuclear cells could be transduced efficiently by the LV that contained the CyPA-binding region of HIV-2. Therefore, this LV might be very useful for long-term safety studies in large animal models like rhesus macaques.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299408     DOI: 10.1038/mt.sj.6300091

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  9 in total

Review 1.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

2.  Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector.

Authors:  Huan He; Jing Xue; Weiming Wang; Lihong Liu; Chaobaihui Ye; Zhe Cong; Jason T Kimata; Chuan Qin; Paul Zhou
Journal:  Hum Gene Ther       Date:  2016-12-29       Impact factor: 5.695

3.  Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells.

Authors:  Naoya Uchida; Kareem N Washington; Jun Hayakawa; Matthew M Hsieh; Aylin C Bonifacino; Allen E Krouse; Mark E Metzger; Robert E Donahue; John F Tisdale
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

4.  Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.

Authors:  Roger G Ptak; Philippe A Gallay; Dirk Jochmans; Andrew P Halestrap; Urs T Ruegg; Luke A Pallansch; Michael D Bobardt; Marie-Pierre de Béthune; Johan Neyts; Erik De Clercq; Jean-Maurice Dumont; Pietro Scalfaro; Kamel Besseghir; Roland M Wenger; Brigitte Rosenwirth
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

5.  Transient in vivo beta-globin production after lentiviral gene transfer to hematopoietic stem cells in the nonhuman primate.

Authors:  Jun Hayakawa; Takahiro Ueda; Leszek Lisowski; Matthew M Hsieh; Kareem Washington; Oswald Phang; Mark Metzger; Allen Krouse; Robert E Donahue; Michel Sadelain; John F Tisdale
Journal:  Hum Gene Ther       Date:  2009-06       Impact factor: 5.695

Review 6.  HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules.

Authors:  Akatsuki Saito; Masahiro Yamashita
Journal:  Retrovirology       Date:  2021-10-26       Impact factor: 4.602

7.  Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection.

Authors:  Maarten A N Rits; Karel A van Dort; Neeltje A Kootstra
Journal:  PLoS One       Date:  2008-12-18       Impact factor: 3.240

8.  The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.

Authors:  Daniëlle van Manen; Maarten A N Rits; Corrine Beugeling; Karel van Dort; Hanneke Schuitemaker; Neeltje A Kootstra
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

9.  Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.

Authors:  Franziska K Geis; Melanie Galla; Dirk Hoffmann; Johannes Kuehle; Daniela Zychlinski; Tobias Maetzig; Juliane W Schott; Adrian Schwarzer; Christine Goffinet; Stephen P Goff; Axel Schambach
Journal:  Retrovirology       Date:  2017-05-31       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.